In what may be the first study to use brain imaging to look at the neural circuits involved in emotional control in patients with depression, researchers at the University of Wisconsin-Madison have found that brains of people with clinical depression react very differently than those of healthy people when trying to cope with negative situations. [continue reading…]
Depression
Experimental medication ketamine relives depression in just hours—Points to targets for new medications
A new study has revealed more about how the medication ketamine, when used experimentally for depression, relieves symptoms of the disorder in hours instead of weeks or months it takes for current antidepressants to work. While ketamine itself probably won’t come into use as an antidepressant because of its side effects, the new finding moves scientists considerably closer to understanding how to develop faster-acting antidepressant medications – among the priorities of the National Institute of Mental Health (NIMH), part of the National Institutes of Health. [continue reading…]
Thomas Joiner, Florida State University Distinguished Research Professor and the Bright-Burton Professor of Psychology, has identified hopelessness as a distinguishing feature of double depression in a new paper published in the Journal of Affective Disorders. The finding could help therapists diagnose and treat the mood disorder. [continue reading…]
A recent study from the University of Alberta and McGill University shows that women who have suffered heart attacks have higher rates of lingering symtoms of depression compared to their male counterparts. [continue reading…]